In many cancers, NF-κB is constitutively active, resulting in elevated expression of NF-κB-target genes that elicit aggressive tumor cell behaviors including enhanced proliferation, survival, migration, invasion, metastasis, and therapy resistance [4], [5]. This evidence concerns the gene NFKB1 and cancer.